Hepamore Tablet is a combination pharmaceutical formulation containing Metadoxine (500 mg), Silymarin (140 mg), L-Ornithine L-Aspartate (150 mg), Vitamin B6 (Pyridoxine) (3 mg), and Folic Acid (1.5 mg), designed to support liver function and promote hepatic detoxification. Metadoxine acts as a hepatoprotective agent by accelerating the metabolism and elimination of toxic substances, thereby reducing oxidative stress and inflammation in hepatic tissues. Silymarin, a well-known antioxidant derived from milk thistle, contributes to hepatocyte regeneration and stabilizes cellular membranes, preventing toxin-induced damage. L-Ornithine L-Aspartate facilitates ammonia detoxification by enhancing the urea cycle, which is critical in managing hepatic encephalopathy and improving nitrogen balance. Vitamin B6 plays a vital role in amino acid metabolism and supports enzymatic functions essential for liver health, while Folic Acid aids in DNA synthesis and repair, further contributing to cellular regeneration. Hepamore Tablet is indicated for patients with acute and chronic liver disorders, including alcoholic liver disease, non-alcoholic fatty liver disease, and drug-induced hepatotoxicity. It is recommended to be used under medical supervision, with dosage tailored according to the severity of liver impairment and patient response. Regular monitoring of liver function tests is advised during therapy to assess efficacy and safety.